These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25497430)

  • 1. New insight into the aetiology of testicular germ cell tumours.
    Huddart R
    Eur Urol; 2015 Apr; 67(4):702-3. PubMed ID: 25497430
    [No Abstract]   [Full Text] [Related]  

  • 2. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model.
    van der Zwan YG; Biermann K; Wolffenbuttel KP; Cools M; Looijenga LH
    Eur Urol; 2015 Apr; 67(4):692-701. PubMed ID: 25240975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ cell cancer risk in DSD patients.
    Cools M
    Ann Endocrinol (Paris); 2014 May; 75(2):67-71. PubMed ID: 24786700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadal tumours and DSD.
    Looijenga LH; Hersmus R; de Leeuw BH; Stoop H; Cools M; Oosterhuis JW; Drop SL; Wolffenbuttel KP
    Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):291-310. PubMed ID: 20541153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible presence of an embryonal carcinoma-associated proteoglycan in the serum of patients with testicular germ cell tumours.
    Mason MD; Pera MF; Cooper S
    Eur J Cancer; 1991; 27(3):300. PubMed ID: 1851027
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor risk in disorders of sex development.
    Pleskacova J; Hersmus R; Oosterhuis JW; Setyawati BA; Faradz SM; Cools M; Wolffenbuttel KP; Lebl J; Drop SL; Looijenga LH
    Sex Dev; 2010 Sep; 4(4-5):259-69. PubMed ID: 20558977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Clinical Applications of Testicular Cancer Biomarkers.
    Mir MC; Pavan N; Gonzalgo ML
    Urol Clin North Am; 2016 Feb; 43(1):119-25. PubMed ID: 26614034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus statement on circulating tumour markers and staging patients with germ cell tumours.
    Rustin GJ; Vogelzang NJ; Sleijfer DT; Nisselbaum JN
    Prog Clin Biol Res; 1990; 357():277-84. PubMed ID: 2170994
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor risk and clinical follow-up in patients with disorders of sex development.
    Cools M; Looijenga LH
    Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():519-24. PubMed ID: 22423509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Levels of Trace Elements in Patients with Testicular Cancers.
    Kaba M; Pirinççi N; Yüksel MB; Gecit İ; Güneş M; Demir M; Akkoyun H; Demir H
    Int Braz J Urol; 2015; 41(6):1101-7. PubMed ID: 26742967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of serum tumour marker monitoring.
    Colls BM
    Br J Cancer; 1991 Apr; 63(4):648. PubMed ID: 1850614
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumors of dysgenetic gonads in intersexes: case reports and discussion regarding their place in gonadal oncology.
    Melicow MM
    Bull N Y Acad Med; 1966 Jan; 42(1):3-20. PubMed ID: 5215586
    [No Abstract]   [Full Text] [Related]  

  • 13. The biology of germ cell tumors in disorders of sex development.
    Hersmus R; van Bever Y; Wolffenbuttel KP; Biermann K; Cools M; Looijenga LH
    Clin Genet; 2017 Feb; 91(2):292-301. PubMed ID: 27716895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in molecular markers of germ cell cancer in patients with disorders of sex development.
    van der Zwan YG; Cools M; Looijenga LH
    Endocr Dev; 2014; 27():172-84. PubMed ID: 25247654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA19-9: a possible serum marker for embryonal carcinoma.
    Tsuruta T; Ogawa A; Ishii K; Ikado S
    Urol Int; 1997; 58(1):20-4. PubMed ID: 9058515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
    Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
    Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of known and novel germ cell cancer-specific (embryonic) miRs in serum by high-throughput profiling.
    Rijlaarsdam MA; van Agthoven T; Gillis AJ; Patel S; Hayashibara K; Lee KY; Looijenga LH
    Andrology; 2015 Jan; 3(1):85-91. PubMed ID: 25382245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germ cell tumours: a scary presentation.
    Oliveira CAB; Costa AC; Mendes V
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32699054
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic factors in metastatic disease.
    Droz JP; Kramar A; Rey A
    Semin Oncol; 1992 Apr; 19(2):181-9. PubMed ID: 1372760
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology and Diagnosis of Testis Cancer.
    Stevenson SM; Lowrance WT
    Urol Clin North Am; 2015 Aug; 42(3):269-75. PubMed ID: 26216814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.